{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T12:03:50Z","timestamp":1702555430280},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41390-022-02237-y","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T06:05:06Z","timestamp":1660197906000},"page":"1208-1215","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Opitz syndrome: improving clinical interpretation of intronic variants in MID1 gene"],"prefix":"10.1038","volume":"93","author":[{"given":"Lucia","family":"Micale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Mascaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Morlino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Nardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Bisceglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germana","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Castori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"2237_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng1197-285","volume":"17","author":"NA Quaderi","year":"1997","unstructured":"Quaderi, N. A. et al. Opitz G\/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat. Genet. 17, 285\u2013291 (1997).","journal-title":"Nat. Genet."},{"key":"2237_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/jmedgenet-2014-102677","volume":"52","author":"P Kruszka","year":"2015","unstructured":"Kruszka, P. et al. Mutations in SPECC1L, encoding sperm antigen with calponin homology and coiled-coil domains 1-like, are found in some cases of autosomal dominant Opitz G\/BBB syndrome. J. Med. Genet. 52, 104\u2013110 (2015).","journal-title":"J. Med. Genet."},{"key":"2237_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/ng1295-459","volume":"11","author":"NH Robin","year":"1995","unstructured":"Robin, N. H. et al. Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2. Nat. Genet. 11, 459\u2013461 (1995).","journal-title":"Nat. Genet."},{"key":"2237_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1086\/302010","volume":"63","author":"K Gaudenz","year":"1998","unstructured":"Gaudenz, K. et al. Opitz G\/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domain. Am. J. Hum. Genet. 63, 703\u2013710 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"2237_CR5","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/hmg\/9.17.2553","volume":"9","author":"TC Cox","year":"2000","unstructured":"Cox, T. C. et al. New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome. Hum. Mol. Genet. 9, 2553\u20132562 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"2237_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/jmg.2003.014829","volume":"41","author":"L Pinson","year":"2004","unstructured":"Pinson, L. et al. Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome. J. Med. Genet. 41, 381\u2013386 (2004).","journal-title":"J. Med. Genet."},{"key":"2237_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.30407","volume":"132A","author":"J So","year":"2005","unstructured":"So, J. et al. Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. Am. J. Med. Genet. A 132A, 1\u20137 (2005).","journal-title":"Am. J. Med. Genet. A"},{"key":"2237_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ymgme.2005.10.014","volume":"87","author":"L Mnayer","year":"2006","unstructured":"Mnayer, L., Khuri, S., Merheby, H. A., Meroni, G. & Elsas, L. J. A structure-function study of MID1 mutations associated with a mild Opitz phenotype. Mol. Genet. Metab. 87, 198\u2013203 (2006).","journal-title":"Mol. Genet. Metab."},{"key":"2237_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/humu.9480","volume":"28","author":"R Ferrentino","year":"2007","unstructured":"Ferrentino, R., Bassi, M. T., Chitayat, D., Tabolacci, E. & Meroni, G. MID1 mutation screening in a large cohort of Opitz G\/BBB syndrome patients: twenty-nine novel mutations identified. Hum. Mutat. 28, 206\u2013207 (2007).","journal-title":"Hum. Mutat."},{"key":"2237_CR10","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","volume":"20","author":"A Reymond","year":"2001","unstructured":"Reymond, A. et al. The tripartite motif family identifies cell compartments. EMBO J. 20, 2140\u20132151 (2001).","journal-title":"EMBO J."},{"key":"2237_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ng762","volume":"29","author":"A Trockenbacher","year":"2001","unstructured":"Trockenbacher, A. et al. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat. Genet. 29, 287\u2013294 (2001).","journal-title":"Nat. Genet."},{"key":"2237_CR12","doi-asserted-by":"publisher","first-page":"8680","DOI":"10.1073\/pnas.1100131108","volume":"108","author":"E Liu","year":"2011","unstructured":"Liu, E., Knutzen, C. A., Krauss, S., Schweiger, S. & Chiang, G. G. Control of mTORC1 signaling by the Opitz syndrome protein MID1. Proc. Natl Acad. Sci. USA 108, 8680\u20138685 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2237_CR13","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1038\/onc.2008.247","volume":"27","author":"A Carracedo","year":"2008","unstructured":"Carracedo, A. & Pandolfi, P. P. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 27, 5527\u20135541 (2008).","journal-title":"Oncogene"},{"key":"2237_CR14","doi-asserted-by":"publisher","first-page":"8970","DOI":"10.1074\/jbc.M512755200","volume":"281","author":"KM Short","year":"2006","unstructured":"Short, K. M. & Cox, T. C. Subclassification of the RBCC\/TRIM superfamily reveals a novel motif necessary for microtubule binding. J. Biol. Chem. 281, 8970\u20138980 (2006).","journal-title":"J. Biol. Chem."},{"key":"2237_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.celrep.2015.12.035","volume":"14","author":"AA Gholkar","year":"2016","unstructured":"Gholkar, A. A. et al. The X-linked-intellectual-disability-associated ubiquitin ligase Mid2 interacts with astrin and regulates astrin levels to promote cell division. Cell Rep. 14, 180\u2013188 (2016).","journal-title":"Cell Rep."},{"key":"2237_CR16","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.bbamcr.2017.07.014","volume":"1864","author":"ME Zanchetta","year":"2017","unstructured":"Zanchetta, M. E., Napolitano, L. M. R., Maddalo, D. & Meroni, G. The E3 ubiquitin ligase MID1\/TRIM18 promotes atypical ubiquitination of the BRCA2-associated factor 35, BRAF35. Biochim. Biophys. Acta Mol. Cell Res. 1864, 1844\u20131854 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"2237_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3389\/fphys.2019.00274","volume":"10","author":"ME Zanchetta","year":"2019","unstructured":"Zanchetta, M. E. & Meroni, G. Emerging roles of the TRIM E3 ubiquitin ligases MID1 and MID2 in cytokinesis. Front. Physiol. 10, 274 (2019).","journal-title":"Front. Physiol."},{"key":"2237_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0690-2","volume":"12","author":"SE Brnich","year":"2019","unstructured":"Brnich, S. E. et al. Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework. Genome Med. 12, 3 (2019).","journal-title":"Genome Med."},{"key":"2237_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"2237_CR20","doi-asserted-by":"crossref","unstructured":"Tompson, S. W. & Young, T. L. Assaying the effects of splice site variants by exon trapping in a mammalian cell line. Bio Protoc. 7, e2281 (2017).","DOI":"10.21769\/BioProtoc.2281"},{"key":"2237_CR21","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"Tayoun Abou","year":"2018","unstructured":"Abou, Tayoun et al. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum. Mutat. 39, 1517\u20131524 (2018).","journal-title":"Hum. Mutat."},{"key":"2237_CR22","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/ejhg.2014.40","volume":"22","author":"AY Steffensen","year":"2014","unstructured":"Steffensen, A. Y. et al. Functional characterization of BRCA1 gene variants by mini-gene splicing assay. Eur. J. Hum. Genet. 22, 1362\u20131368 (2014).","journal-title":"Eur. J. Hum. Genet."},{"key":"2237_CR23","doi-asserted-by":"publisher","first-page":"e1006691","DOI":"10.1371\/journal.pgen.1006691","volume":"13","author":"E Fraile-Bethencourt","year":"2017","unstructured":"Fraile-Bethencourt, E. et al. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18. PLoS Genet. 13, e1006691 (2017).","journal-title":"PLoS Genet."},{"key":"2237_CR24","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1515\/cclm-2014-1047","volume":"53","author":"G Giorgi","year":"2015","unstructured":"Giorgi, G. et al. Validation of CFTR intronic variants identified during cystic fibrosis population screening by a minigene splicing assay. Clin. Chem. Lab. Med. 53, 1719\u20131723 (2015).","journal-title":"Clin. Chem. Lab. Med."},{"key":"2237_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fgene.2018.00007","volume":"9","author":"O Villate","year":"2018","unstructured":"Villate, O. et al. Functional analyses of a novel splice variant in the CHD7 gene, found by next generation sequencing, confirm its pathogenicity in a Spanish patient and diagnose him with CHARGE Syndrome. Front. Genet. 9, 7 (2018).","journal-title":"Front. Genet."},{"key":"2237_CR26","doi-asserted-by":"crossref","unstructured":"Morbidoni, V. et al. Hybrid minigene assay: an efficient tool to characterize mRNA splicing profiles of NF1 variants. Cancers 13, 999 (2021).","DOI":"10.3390\/cancers13050999"},{"key":"2237_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0092-8674(00)80542-5","volume":"96","author":"MW Hentze","year":"1999","unstructured":"Hentze, M. W. & Kulozik, A. E. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96, 307\u2013310 (1999).","journal-title":"Cell"},{"key":"2237_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/sj.ejhg.5201889","volume":"15","author":"L Linde","year":"2007","unstructured":"Linde, L. et al. The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells. Eur. J. Hum. Genet. 15, 1156\u20131162 (2007).","journal-title":"Eur. J. Hum. Genet."},{"key":"2237_CR29","doi-asserted-by":"crossref","unstructured":"Lejeune, F. Nonsense-mediated mRNA decay, a finely regulated mechanism. Biomedicines 10, 141 (2022).","DOI":"10.3390\/biomedicines10010141"},{"key":"2237_CR30","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/hmg\/ddz028","volume":"28","author":"H Sarkar","year":"2019","unstructured":"Sarkar, H. et al. Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics. Hum. Mol. Genet. 28, 1865\u20131871 (2019).","journal-title":"Hum. Mol. Genet."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02237-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T15:10:43Z","timestamp":1682521843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02237-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2237"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02237-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"COMPETING interests"}},{"value":"Written informed consent was obtained from all individuals for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}